<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: 4-<z:chebi fb="1" ids="22927,47265">bromo</z:chebi>-2,5-dimethoxyphenethylamine (2C-B) is a designer-drug variant of <z:chebi fb="0" ids="1391">3,4-methylenedioxymethamphetamine</z:chebi> (ecstasy) whose recreational use has increased significantly over the last 10 years </plain></SENT>
<SENT sid="1" pm="."><plain>Neurologic consequences of 2C-B usage are currently unknown </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: A 43-year-old woman experienced severe <z:hpo ids='HP_0002315'>headaches</z:hpo> within 48 hours of taking liquid 2C-B, after which time she developed <z:hpo ids='HP_0002448'>progressive encephalopathy</z:hpo> and quadraparesis, which did not improve over several months </plain></SENT>
<SENT sid="3" pm="."><plain>MRA and cerebral angiogram imaging demonstrated profound <z:hpo ids='HP_0002597'>vascular abnormalities</z:hpo> of large, medium, and small-caliber vessels with subsequent watershed infarction </plain></SENT>
<SENT sid="4" pm="."><plain>Brain biopsy and cerebrospinal fluid studies ruled out an inflammatory process </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: This case demonstrates an idiosyncratic and devastating neurologic response to 2C-B, a recreational drug whose popularity has increased with widespread availability of online guides for its synthesis </plain></SENT>
</text></document>